ERLIN2 and breast carcinoma: Wang and colleagues [113] found that amplification of the ERLIN2 gene and its resulting overexpression occurs in both luminal and Her2+ subtypes of breast cancer, suggesting a role for ERLIN2 as a novel oncogenic factor under the ER stress response pathway.